Insider Transactions in Q2 2022 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,975
-3.08%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
3,092
-2.61%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
3,144
-1.09%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,613
-1.96%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
2,613
-2.3%
|
$0
$0.37 P/Share
|
|
May 26
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,005,686
-12.5%
|
$0
$0.36 P/Share
|
|
May 25
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,434,509
-15.13%
|
$0
$0.42 P/Share
|
|
May 24
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
144,805
-1.5%
|
$0
$0.51 P/Share
|
|
May 23
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,250,000
-11.49%
|
$0
$0.65 P/Share
|